HIMS - CIK 0001773751
Hims & Hers Health, Inc. trades as HIMS and has a market capitalization of $6.01 B, making it the #1266 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $2.35B, up 59.0% from the prior year and net income of $128.37M. This page tracks Hims & Hers Health, Inc. through 1,203 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 6 fiscal years Hims & Hers Health, Inc.'s revenue grew from $82.56M to $2.35B, a compound annual growth rate of 74.7%. Net profit margin expanded from -87.3% to 5.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Major company event | 8-K | 2026-05-21 |
| Insider trade | 4 | 2026-05-19 |
| Major company event | 8-K | 2026-05-19 |
| SCHEDULE 13G | - | 2026-05-15 |
_By introducing access to generic semaglutide in Canada, the company is meeting the needs of a dynamic market and continuing its international expansion efforts_
_Revenue of approximately $608 million, up 4% year-over-year in Q1 2026_
_If elected, the marketing leader from transformative companies like DoorDash and Meta will join a diverse board with medical, tech, and consumer expertise_
The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year.
_Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill_
The largest companies sharing Hims & Hers Health, Inc.'s SEC industry classification (services-offices & clinics of doctors of medicine).
Hims & Hers Health, Inc. (HIMS) has a market capitalization of $6.01 B as of 2026-05-29, ranking #1266 among US-listed companies.
Hims & Hers Health, Inc. reported revenue of $2.35B for fiscal year 2025, an increase of 59.0% year over year.
Yes. Hims & Hers Health, Inc. reported net income of $128.37M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.